Stanford’s noninvasive brain treatment for depression proves helpful

Valerie Zeko emerged from 28 years of debilitating depression after participating in a groundbreaking trial at Stanford, ...
MedPage Today on MSN

FDA approves at-home device for treatment-resistant depression

The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...

Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepres…

Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today ...
Medical Dialogues

FDA Approves First At-Home Brain Neuromodulation Device for Depression

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...
MPR

FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

BrainsWay’s strategic investment in Neurolief paved the way for the first and only FDA approved at-home neuromodulation ...
MassDevice

Neurolief gets FDA approval for at-home neuromod that treats depression

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...
The Scientist

The Ear as a Therapeutic Gateway to the Vagus Nerve

Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease ...
Business Wire

Personalized Neuromodulation Treatment Significantly Slowed Alzheimer’s Progression in 12-month Phase 2 Study, Meeting Primary and Key Secondary Endpoints

Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog 11 ...
Psychology Today

Neuromodulation in Addiction Treatment

When most people consider treatment for psychiatric problems, they usually consider medications and/or psychotherapy. However, emerging neuromodulation approaches using transcranial magnetic ...

Enspire DBS Therapy Announces $10.3 Million Series B1 Financing to Advance Pivotal Development of DBS-Enabled Stroke Rehabilitation

Financing led by Genesys Capital with participation from Cleveland Clinic and JobsOhio Ventures -- Genesys Capital Managing Partner Jamie Stiff to join Enspire Board of Directors -- Proceeds to ...